Premium Information is available for this item - Upgrade for $1 a day
6505-01-162-2945
Usp Clorazepate Dipotassium Tablets
6505011622945 011622945 TRANXENE TABLETS NDC00074-4391-13 NDC00005-3436-23
January 2023
6
Marketplace 6505-01-162-2945
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-162-2945 5+ Documents (More...)
011534377 TRANXENE TABLETS (Active) Primary Buy RNCC 3 RNVC 2 DAC 4 TRANXENE TABLETS 60060 - Abbott
(Active) Primary Buy RNCC 3 RNVC 2 DAC 4 TRANXENE TABLETS 60060 - Abbott Laboratories Inc. 153
Documents 6505-01-252-0802 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-162-2945
your Account Upgrade 6505-01-153-4377Usp Clorazepate Dipotassium Tablets6505011534377 011534377 TRANXENE TABLETS
Dipotassium Tablets your Account Upgrade 6505-01-162-2945Usp Clorazepate Dipotassium Tablets6505011622945 011622945
your Account Upgrade 6505-01-153-4377Usp Clorazepate Dipotassium Tablets6505011534377 011534377 TRANXENE TABLETS
Dipotassium Tablets your Account Upgrade 6505-01-162-2945Usp Clorazepate Dipotassium Tablets6505011622945 011622945
your Account Upgrade 6505-01-153-4377Usp Clorazepate Dipotassium Tablets6505011534377 011534377 TRANXENE TABLETS
Restrictions 6505-01-162-2945
6505-01-162-2945 is a Usp Clorazepate Dipotassium Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-162-2945
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-162-2945
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-162-2945
- Part Number
- Manufacturer
- Status
- NDC00074-4391-13
- Manufacturer
- 60060 - Abbott Laboratories Inc. (Active)
- Primary Buy
- Primary Buy
- TRANXENE TABLETS
- 60060 - Abbott Laboratories Inc. (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
- NDC00005-3436-23
- 06404 - American Cyanamid Co (Obsolete)
- Canceled/Obsolete
- Canceled/Obsolete
Datasheet 6505-01-162-2945
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 15.000 Milligrams Clorazepate Dipotassium Active Ingredient
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 100.000 Tablets
- Supplementary Features [SUPP]
- Medsep Item For Dod,Abbott Labs
- Protective Storage Feature [AJCN]
- Security Storage
Management Data 6505-01-162-2945
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Oct 1991
- Veterans Administration (VA)
- BT
- Subscribe
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 100 Tt
- 00000000100TT
- K
NATO Stock Numbers Related to 6505-01-162-2945
Freight Information 6505-01-162-2945
6505-01-162-2945 has freight characteristics managed by the Bonneville Power Administration.. 6505-01-162-2945 has a variance between NMFC and UFC when transported by rail and the description should be consulted.